Rani Therapeutics Holdings Inc Cl A (RANI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Sales | 0 | 0 | 1,961 | 756 | 0 |
| Gross Profit | 0 | N/A | 1,961 | 756 | N/A |
| Operating Expenses | 13,362 | 27,781 | 7,219 | 5,954 | 0 |
| Operating Income | -13,362 | -27,781 | -5,258 | -5,198 | N/A |
| Interest Expense | -1 | 110 | 169 | 188 | 0 |
| Other Income | 16 | -772 | -57 | -169 | 0 |
| Pre-tax Income | -13,345 | -28,663 | -5,484 | -5,555 | 0 |
| Income Tax | -40 | 37 | 1 | 43 | N/A |
| Net Income Continuous | -13,305 | -28,700 | -5,485 | -5,598 | N/A |
| Minority Interests | -8,116 | -25,558 | -5,485 | -5,598 | N/A |
| Net Income | $-5,189 | $-3,142 | $N/A | $N/A | $N/A |
| EPS Basic Total Ops | -0.27 | -0.16 | N/A | N/A | N/A |
| EPS Basic Continuous Ops | -1.24 | -1.48 | N/A | N/A | N/A |
| EPS Diluted Total Ops | -0.27 | -0.16 | N/A | N/A | N/A |
| EPS Diluted Continuous Ops | -1.24 | -1.48 | N/A | N/A | N/A |
| EBITDA(a) | $-13,249 | $-27,661 | $-5,130 | $-5,062 | $N/A |